Foster innovation

By using cutting-edge academic expertise and technology services to de-risk and improve the translation of academic and SME-driven developments towards the patient, EATRIS enhances biomedical innovation in Europe, and acts as an EU reference point where all stakeholders involved in the translational medicine value chain can work together.

Flagship efforts fostering innovation are the IMI projects EU-Pearl and EPND, the GlaxoSmithKline Imaging Hub conceptualized and managed by EATRIS, and the REMEDi4ALL repurposing project driving the future of drug repurposing in Europe.

Additional efforts include the recent inception of EATRIS Expert Centres providing crucial but scarce knowledge to advance the development plan of translational projects – supporting innovation. These services cover a range of areas, such as innovation management, regulatory strategy, translational feasibility, and early health technology assessment.